Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs Artificial Tears for Post-Intravitreal Injection Pain
NCT06130384Phase 4Completed
- Sponsor
- Wills Eye Hospital
- Start
- Mar 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of bromfenac sodium in procedural pain (2 arms), sponsored by Wills Eye Hospital. Primary endpoints: Short Form McGill Pain Questionnaire Present Pain Intensity score at 5 months and Wong-Baker FACES Pain Rating Scale at 5 months. Started Mar 2021; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06130384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06130384.